Computers in Drug Research and Development

Computers in drug research and development become more powerful as computers become more powerful, and their use and ability are growing. Scientists have used this power to help achieve the goals of research and development of human drugs. Computers are located in almost all drug research laboratories and development centers. Thousands of compounds were tested for laboratory tests and animal testing during drug development. Normally, more than 5,000 compounds are selected for such testing.

Atomwise is a San Francisco-based start-up company that is developing a supercomputer designed to enhance the drug development process to replace the test tube. Testing cell types, gene combinations, and other biological processes takes considerable time in the pharmaceutical process. On average, it will take 12 to 14 years for drugs to be fully equipped in the market. Speeding up this process increases efficiency and saves time. I made progress. The benefits of deep learning in AI / ML and the medical field have unlimited potential in the industrial revolution. Artificial intelligence will continue to be an important part of concrete and professional work from pharmaceutical to imaging and oncology. Aside from the profitability of the business, almost all companies stated that companies entering this field are doing their utmost to find solutions to some of the most mysterious health problems in the world.

Big money and state-of-the-art technology: How to invest in AI / ML to revolutionize the healthcare industry

Whether artificial intelligence can fulfill its commitment to improve the efficiency of drug development in recent years has raised many people's doubts. It is no exaggeration to say that the use of these calculation tools now has the possibility of incredible disease target recognition, compound screening, de novo drug design and clinical prediction. This is reflected not only in the increase in the number of technology providers but also in the widespread recruitment and testing of the pharmaceutical industry. It is worth noting that BenevolentAI and Johnson & Johnson are taking Phase IIb clinical trials through machine learning, taking drugs to improve Parkinson 's drowsiness. Many other pharmaceutical companies and biotechnology companies are beginning to cooperate with several artificial intelligence companies to benefit from advances in machine learning and supercomputing, but investing in appropriate machine learning techniques It is important for the company.